Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial
Pieber T, R Aronson R, Hövelmann U et al
Diabetes Care 2021 Apr; dc202995.
https://doi.org/10.2337/DC20-2995
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants
Zhou, Z., Macpherson, J., Gray, S.R. et al.
Diabetologia. 2021 Jun 10.
https://doi.org/10.1007/s00125-021-05484-6
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen, Y., Zhang, P., Wang, J. et al.
Diabetologia june 64:1279–1287 (2021)
https://doi.org/10.1007/s00125-021-05401-x
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin R, Brown F, James S, Jones J, Ekinci E
Diabetic Medicin May:38:5:e14560
https://doi.org/10.1111/dme.14528
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
Ahuja V, Aronen P, Pramodkumar T, Looker H, Chetrit A, Bloigu A et al
Diabetes Care 2021 Apr; 44 (4): 1062-1069.
https://doi.org/10.2337/dc20-1688
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study
Lega I, Campitelli M, Austin P, Na Y, Zahedi A, Leung F et al
Diabetologia 2021 may:64: 1093–1102
https://doi.org/10.1007/s00125-020-05370-7
Comentarios recientes